Skip to main content
. Author manuscript; available in PMC: 2012 Jan 10.
Published in final edited form as: Mutat Res. 2010 Oct 28;706(1-2):13–20. doi: 10.1016/j.mrfmmm.2010.10.005

Table 3.

Associations between RPS6KA2 and rectal cancer

Rectal
Controls Cases Cases

N N OR1 (95% CI)
RPS6KA2 rs10946164(C>T)
CC 312 292 1.00
CT/TT 647 462 0.78 (0.63, 0.95)
P max 0.02
RPS6KA2 rs9347128(C>G)
CC/CG 791 585 1.00
GG 168 169 1.34 (1.05, 1.71)
P max 0.03
RPS6KA2 rs9295361(C>A)
CC/CA 920 710 1.00
AA 39 44 2.00 (1.24, 3.23)
p max 0.21
RPS6KA2 rs6911624(G>A)
GG 614 530 1.00
GA 308 206 0.77 (0.62, 0.95)
AA 37 18 0.58 (0.32, 1.04)
p max 0.01
RPS6KA2 rs2345067(T>C)
TT 267 235 1.00
TC 463 358 0.85 (0.68, 1.06)
CC 229 161 0.73 (0.56, 0.97)
p max 0.22
RPS6KA2 rs2072638(T>C)
TT/TC 872 643 1.00
CC 79 102 1.79 (1.31, 2.45)
p max <0.01
RPS6KA2 rs7745781(A>G)
AA 730 520 1.00
AG/GG 229 234 1.40 (1.13, 1.74)
1

Adjusted for age, center, race/ethnicity, and sex.